This book observes the idea of race as a false representation for the cause of disease. Race-based medicine, an emerging field in pharmacology, aims to create a specialty market based on racial groups. Within this market, the drug Bi Dil set a precedent in this area of medicine targeting African Americans as its first racial group. Consequently, selecting African Americans as a “starter group” led to ethical questions regarding the motive behind race-based medicine within the context of the larger treatment of blacks in American medical history. This book therefore links medicine and American eugenics, examines race-based medicine’s influence on the perception of the black body, traces the influence of Bi Dil’s approval on the resurgence of race-based medicine, and assesses the black church’s response to race-based medicine using black liberation theology as a means to social justice.
قائمة المحتويات
Chapter 1 Introduction.- Chapter 2 Race-Based Medicine.- Chapter 3 Maleficence toward the Minority Patient.- Chapter 4 Research, Race, and Profit.- Chapter 5 Black Theology and Reconciliation.- Chapter 6 Conclusion.- Bibliography.
عن المؤلف
Dr. Kirk A. Johnson teaches at Seton Hall University and Berkeley College in New Jersey, US. He is a member of the American Society of Bioethics and Humanities and The New York Academy of Medicine. He serves as a member of the Atlantic Health Systems Bioethics Committee and was formerly Assistant Director of the Medical Humanities program at Drew University in Madison, New Jersey, US.
المزيد من الكتب الإلكترونية من نفس المؤلف (المؤلفين) / محرر
8٬088 كتب إلكترونية في هذه الفئة
